To Expand the Service Network, Prodia Launches Kemang Branch

JAKARTA, 12 March 2019 – In line with Prodia’s commitment to provide qualified medical check-up services for all people, PT Prodia Widyahusada Tbk (Ticker Symbol: PRDA) has launched Prodia Health Care branch in Kemang, Jakarta to continue its service expansion.  The new Prodia Health Care clinic is located in Ruko Promenade 20, Jl. Bangka Raya, Mampang Prapatan, Jakarta Selatan. The launching was attended by Reni Susanti and Fitrilia Ulfa Karina from the Technical Service Department of One-Stop Integrated Service (PTSP) of Mampang Prapatan sub-district; Dewi Muliaty, Prodia’s Managing Director; Indriyanti Rafi Sukmawati, Prodia’s Business & Marketing Director; Hanna Trisnawati, Prodia Kemang Branch Manager; and also other Prodia’s line management.

Prodia’s Managing Director Dewi Muliaty said that the launching of Prodia Kemang is a Company’s attempt to expand its services. “Prodia Health Care Kemang will contribute to the community residing around the branch through its comprehensive medical check-up services. Prodia is committed to providing qualified and advanced services to meet the people’s increasing needs of medical checkup,” said Dewi during the Grand Opening of Prodia Health Care Kemang (12/03).  

Having obtained the clinical laboratory permit, Prodia Health Care Kemang provides medical services such as general medical checkup, general practitioners services, physician nutrition specialist services on physical wellness, vaccination, basic and premium wellness check-up panels for both men and women, Fat Loss Panel, and other laboratory services. One of the general practitioners and the physician nutrition specialists providing services at PHC Kemang are dr. Shella Pratiwi and dr. Arti Indira, Sp.GK. PHC is developed to extend the predictive, preventive, and personalized wellness services to meet the customers’ needs. Supported with the quality Prodia Referral Center Laboratory, PHC may provide medical check-up services for patients with or without specific illnesses who wish to stay healthy and fit and avoid complication.  

“As the pioneer and frontier in the clinical laboratory industry, we have diverse kinds of tests accessible by the customers who wish to regularly check their health condition. Currently, there are approximately 700 medical check-up tests carried out solely by Prodia. Every year we try to develop new tests and improve the existing panels and services,” explained Indriyanti Rafi Sukmawati, Prodia’s Business & Marketing Director.    

Prodia has also launched CArisk test, a genomic test to analyze more than 64 genes and 65 variety of risks related to 9 types of cancer such as breast cancer, colon/colorectal cancer, cervix cancer, liver cancer, pancreas cancer, lung cancer, stomach cancer, thyroid cancer, and uterus cancer. In addition to CArisk, Prodia has also provided other risk genomic tests to map the risks of cardiovascular diseases, hypertension, diabetes, and autoimmune diseases based on the genetics.

Additionally, Prodia also provides several new tests such as gene mutation test EGFR ctCDNA and EGFR Mutation T790M ultrasensitive test for the treatment of lung cancer; ProHealthy Gut for intestinal health checkup; ProSafe for non-invasive prenatal testing (NIPT), which is a prime diagnostic test to detect Down syndrome during pregnancy; and referral cooperation for Telomere Analysis to provide information on human biological age. Prodia is the pioneer of clinical laboratory in Indonesia that serves the latest medical tests.  

Currently, Prodia has e-Prodia facility which is an online registration and payment system for Prodia’s customers. This facility accommodates the customers’ needs to register, choose the desired type of checkups, determine the check-up location, and make the payment in their favor. The online Registration, Payment, and Result System are accessible through your PC, tablet, iPad, and cellphone.

To provide more personal services, Prodia has launched Contact Prodia 1500-830 and an online virtual personal assistant called Tanya Prodia (TANIA). The customers of Prodia may access TANIA online anytime, anywhere through LINE: @prodia.id, Telegram: @prodia.id, Facebook Messenger: @prodia.id, and Prodia’s Website: www.prodia.co.id.

*****
About PT Prodia Widyahusada Tbk
 
Prodia Clinical Laboratory was initially established in Solo on 7 May 1973 by a group of idealist pharmacists. Mr. Andi Widjaja along with the other founders have been committed to present the best test results with wholehearted services.

As the market leader, since 2012 Prodia has been the only laboratory and clinic in Indonesia accredited by the College of American Pathologists (CAP). It implies that the quality of the test result from Prodia’s laboratory is equal to those of international laboratories.
 
On 7 December 2016, the Indonesia Stock Exchange officially listed the initial public offering of Prodia as the 15th issuer in 2016, with the ticker symbol ‘PRDA’. In that corporate action, Prodia offered 187.5 million shares. Accordingly, the fund raised from the Company’s initial public offering (IPO) was Rp1.22 trillion.

Currently, Prodia has had the service network that incorporates 294 outlets, consisting of 144 clinical laboratories across 34 provinces and 123 cities in Indonesia, Prodia Health Care (PHC) - a personalized medicine-based wellness clinic - and specialty clinics, including Prodia Children’s Health Centre (PCHC), Prodia Women’s Health Centre (PWHC), and Prodia Senior Health Centre (PSHC).    
 
For further information, please contact:

Marina Eka Amalia                                                                                           
Legal Head & Corporate Secretary
PT Prodia Widyahusada Tbk                
Ph. +62-21-3144-182 ext. 3816                
E-mail: corporate.secretary@prodia.co.id